You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Complement C4

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • +2 more
    • (no location specified)
    Jul 21, 2023

    New Complement Components in Childhood Lupus Nephritis

    Not yet recruiting
    • Lupus Nephritis
    • C4d evaluation in lupus nephritis in serum and renal tissue
    • (no location specified)
    Oct 7, 2021

    Paroxysmal Nocturnal Hemoglobinuria, C3 Glomerulopathy, IgA Nephropathy Trial in Korea, Republic of, New Zealand, Thailand

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • +2 more
    • Camperdown, New South Wales, Australia
    • +19 more
    Sep 13, 2022

    Complement C5a Receptors in Hidradenitis Suppurativa

    Recruiting
    • Hidradenitis Suppurativa
      • Redwood City, California
        Stanford University
      Jun 27, 2022

      Hemolytic-Uremic Syndrome, Membranoproliferative Glomerulonephritis, Healthy Trial in Ranica (C3NEF assay)

      Not yet recruiting
      • Hemolytic-Uremic Syndrome
      • +2 more
      • C3NEF assay
      • Ranica, BG, Italy
        Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
      Aug 9, 2023

      C3G, IC-MPGN, C3 Glomerulopathy Trial (Pegcetacoplan)

      Not yet recruiting
      • C3G
      • +11 more
      • (no location specified)
      Apr 13, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial (Danicopan)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Baltimore, Maryland
      • +4 more
      Feb 1, 2023

      Covid19, Thrombotic Microangiopathies, Acute Kidney Injury Trial in Boston (Ravulizumab)

      Active, not recruiting
      • Covid19
      • +2 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Dec 31, 2022

      C3G Trial in Worldwide (Placebo, iptacopan)

      Recruiting
      • C3G
      • Aurora, Colorado
      • +60 more
      Nov 23, 2022

      C3 Glomerulopathy (C3G) Trial (Iptacopan)

      Available
      • C3 Glomerulopathy (C3G)
      • (no location specified)
      Jan 24, 2023

      C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality Trial in Sweden (Aliskiren, Enalapril)

      Recruiting
      • C3 Glomerulopathy
      • +4 more
      • Gothenburg, Sweden
      • +3 more
      Jan 4, 2022

      Stargardt Disease 1 Trial in Worldwide (Zimura, Sham)

      Recruiting
      • Stargardt Disease 1
      • Phoenix, Arizona
      • +41 more
      Sep 7, 2022

      Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Iptacopan)

      Recruiting
      • Atypical Hemolytic Uremic Syndrome
      • Torrance, California
      • +19 more
      Aug 10, 2022

      Complement Activation in the Lysosomal Storage Disorders

      Withdrawn
      • Fabry Disease
      • +3 more
      • Complement measurements
      • Melbourne, Victoria, Australia
        The Royal Melbourne Hospital
      Jun 2, 2021

      Pleural Effusion Trial in Jakarta Pusat (procedure, diagnostic test, drug)

      Not yet recruiting
      • Pleural Effusion
      • Medical thoracoscopy
      • +2 more
      • Jakarta Pusat, DKI Jakarta, Indonesia
        Respirology and Critical Illness Division, Department of Interna
      Sep 21, 2022

      Traumatic Brain Injury, Trauma, Head Trial in Den Haag, Leiden, Rotterdam (C1 Inhibitor, Human, Placebo)

      Recruiting
      • Traumatic Brain Injury
      • Trauma, Head
      • C1 Inhibitor, Human
      • Placebo
      • Den Haag, Netherlands
      • +2 more
      Sep 6, 2021

      Healthy Trial in Porto (HVLA C3/C4 manipulation, Sham technique)

      Not yet recruiting
      • Healthy
      • HVLA C3/C4 manipulation
      • Sham technique
      • Porto, Portugal
        Escola Superior da Saúde do Porto
      Mar 23, 2022

      HIV-1-infection Trial in United States (426c.Mod.Core-C4b 30 mcg, 426c.Mod.Core-C4b 100 mcg, 426c.Mod.Core-C4b 300 mcg)

      Recruiting
      • HIV-1-infection
      • 426c.Mod.Core-C4b 30 mcg
      • +3 more
      • Birmingham, Alabama
      • +5 more
      Jul 25, 2022

      C3G, IC-MPGN, C3 Glomerulopathy Trial in Worldwide (Pegcetacoplan, Placebo)

      Recruiting
      • C3G
      • +11 more
      • Birmingham, Alabama
      • +27 more
      Aug 4, 2022

      Geographic Atrophy, Macular Degeneration Trial in Dallas (Avacincaptad pegol 2 mg intravitreal injection)

      Not yet recruiting
      • Geographic Atrophy
      • Macular Degeneration
      • Avacincaptad pegol 2 mg intravitreal injection
      • Dallas, Texas
        Retina Foundation of the Southwest
      Sep 7, 2022

      Data Obtained With LuGENE® Multiparameter Transcriptomics Blood

      Not yet recruiting
      • Lupus Erythematosus, Systemic
      • Decision Support Test
      • (no location specified)
      Apr 25, 2023

      C3G, IC-MPGN, Renal Transplant Trial in Worldwide (Pegcetacoplan)

      Recruiting
      • C3G
      • +11 more
      • Los Angeles, California
      • +21 more
      Apr 5, 2022

      HIV Trial in Rochester, Nashville, Seattle (HIV-1 C4-V3 Polyvalent Peptide Vaccine)

      Completed
      • HIV Infections
      • HIV-1 C4-V3 Polyvalent Peptide Vaccine
      • Rochester, New York
      • +2 more
      Oct 27, 2021

      HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)

      Recruiting
      • HIV Vaccine
      • HIV-1-infection
      • C62
      • +4 more
      • Chapel Hill, North Carolina
      • +1 more
      Oct 27, 2022

      Cervical Multifidus Muscle Area on Interlaminar Epidural Steroid

      Not yet recruiting
      • Cervical Radiculopathy
      • Cervical multifidus muscle area measurement at 3 levels (C4-C5, C5-C6, C6-C7)
      • (no location specified)
      Jul 14, 2023